Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Ahmet Sevindik

Set Alert for Articles By Ahmet Sevindik

Latest From Ahmet Sevindik

‘World First’ CCHF Vaccine To Invigorate Turkey’s Vaccine Ambitions?

Turkey’s health ministry has disclosed that a local university is close to successfully developing what it believes is the world’s first vaccine against Crimean-Congo hemorrhagic fever, under a 2015 collaboration with the Cuban government. But other efforts to build domestic vaccine production capacity are largely stalled over tender concerns.

Vaccines Turkey

Turkey Spinraza Access Scheme Falls Far Short Of Demand

Turkey has agreed to provide the high-priced spinal muscular atrophy drug Spinraza for free to up to 20 children, but has so far not been able to reach an agreement with the producer to procure the drug at a reduced price or add it to the reimbursement list.

Policy Turkey

Turkey Cancer Drug Proposal Swims Against Cost Control Tide

The president of Turkey has announced a plan for the cost of all cancer drugs to be paid by the government without any contribution from patients, including products licensed for different indications but which might be used off-label. But the move would add to an already rising bill and seems to go against an established trend of cost control.

Turkey Reimbursement

Turkish Industry Group Builds New Platform To Support Biotech

A major local pharmaceutical industry group in Turkey is leading the formation of a new biotechnology platform that will focus on lobbying the government to create a more friendly investment environment, and promote joint projects and training. Given ongoing official moves to attract investments in the pharma and biotech field, the initiative appears to align well with broader existing policies.

Turkey Biologics

Turkey Sets Wave Of Reimbursement Hikes Across 160-Plus Medical Products

Turkey's public health care payor has increased reimbursement prices of over 160 medical devices, the first time in almost 10 years. It has also eased the reimbursement process for patients to increase their access to medical products.

Turkey Reimbursement

Could The City Hospitals Project Be A Bit Of A Turkey?

As Turkey’s City Hospitals project goes underway, with the first few hospitals already up and running, big medtech players are swooping down to capitalize on this opportunity which promise to boost the Turkish market by up to TRY2bn. However, intense competition, as well as basic problems that had been plaguing companies operating in that country, persists and still needs to be resolved.

Turkey Commercial
See All